1Pekary A E, Hershman J M, Ber L. Tumor necrosis factor, ceramide, transforming growth factor-β1, and aging reduce Na^+/1-symporter messenger ribonucleic acid levels in FRTL-5cells[J]. Endocrinology, 1998,139(2) :703-712.
2Pekary A E, Berg L, Sanfini F, et al. Cytokines modulate type Ⅰ iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cell[J]. Mol Cell Endocrinol, 1994,101 (1-2) : R31 - R35.
3Toda S, Matsumura S, Fujitani N, et al. Transforming gowth factor-β1 induces a mesenchyme-like cell shape without epithelial polarization in thyro-cytes and inhibits and inhibits thyroid folliculogenesis in collagen gel culture[J]. Endocrinology, 1997,138(12) :5 561 - 5 575.
4Cameiro C, Alvare'z C V, Zalvide J, et al. TGF-β1 actions on FRTL- 5cells provide a model for the physiological regulation of thyroid growth[J].Oncogene, 1998,16 (11 ) : 1 455 - 1 465.
5Logan A, Smith C, Peeks G P, a al. Enhanced expression of transforming growth faetor-β1 during thyroid hyperplasia in rats[J]. J Endocrinol, 1994,141(1):45 -57.
6Amis L M, Kaempf J, Gruenigen C V, et al. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-β1 (TGF-β1) [ J ]. J Endoerinol, 1996, 149 (3) :485 - 496.
7Contempre B. Effects of selenium deficiency on thyroidnecrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur J Endecrinol,1995,133(1 ) :99 - 109.
8Holting T, Zielke A, Siperstein A E, a al. Transforming growht factor-β1 is a negative regulator for differentiated thyroid canceraaa: Studies of growth, migration, invasion, and adhesion of cultured folliculary throid cancer cell lines[J]. J Clin Endoerinol Metab, 1994,79(3):806- 813.
9Guimaraes V C. lmmunosuppression of thyroiditis [ see connents ]. Endocrinol, 1996,137(6) :2 199.
10Corica F, Allegra A, Corsonello A, et al. Increased transforming growth factor-β1 plasma concentration is associated with high plasma 3,3 ,5-tri-iodothyronine in alderly patients with nonthyroidal illnesses[J]. Eur J Endocrinol, 1998,138( 1 ) :47 - 50.
